Matri Launches India's Slimmest Dual Mode Period Pain Relief Device - Now Available Exclusively on MyMatri.com
VMPL
Kolkata (West Bengal) [India], May 24: Matri, a fast-growing startup in the menstrual wellness space, has launched Matri Pro, India's slimmest and most advanced period pain relief device. This revolutionary product is now exclusively available on the brand's official website, www.mymatri.com, a direct-to-consumer platform committed to women's wellness.
Backed by science and inspired by real experiences, Matri Pro is designed to provide drug-free, non-invasive menstrual pain relief using a combination of advance TENS technology. The result is a wearable solution that offers instant cramp relief, enhances comfort, and empowers women during their period.
Born from Passion and Purpose:
The journey of Matri began during the second year of engineering for co-founders Roni Mondal and Rohan Roy, who saw firsthand the lack of effective solutions for period pain in India. In 2020, they incorporated the company using their personal savings, with a vision to transform menstrual care through innovation. Their dedication and product innovation earned national attention when Matri was featured on Shark Tank India Season 3, showcasing their commitment to solving one of the most common yet underserved health concerns.
Designed for Today's Women:
Matri Pro is built with modern lifestyles in mind. Whether at work, traveling, or at home, the device fits discreetly under clothing, offering continuous relief without the side effects of medication. Its dual-mode system allows users to switch between TENS and ComfortWave™ depending on comfort, making it one of the most customizable pain relief devices in the market.
Key Features of Matri Pro:
Matri Pro is the slimmest period pain relief device in India. Designed with versatility in mind, it offers dual modes, both wired and wireless, integrated into the same device. Use it wirelessly for maximum freedom of movement or switch to wired mode when needed, depending on your comfort and convenience. It features 30 adjustable intensity levels for personalized pain management and a smart memory mode that resumes from your last setting. The device is USB rechargeable, promoting sustainable use, and is a CDSCO Certified Class B Medical Device, ensuring quality and safety. Matri Pro comes with reusable gel pads, each pair lasting up to 30 uses. It is lightweight, wearable, and travel-friendly, making it ideal for daily life and on-the-go relief. Clinically tested and safe for regular use, Matri Pro embodies comfort, innovation, and trusted menstrual wellness.
These features ensure that Matri Pro meets both medical standards and real-life comfort, making it an ideal choice for women looking for reliable and sustainable menstrual care.
Building a Direct Connection with Women:
Available exclusively on MyMatri.com, the brand's direct-to-consumer platform, Matri Pro is supported by a complete ecosystem of educational content, customer support, and bundled wellness kits. Unlike generic marketplaces, MyMatri.com provides a personalized shopping experience, tailored for the modern Indian woman.
The website also includes other women's wellness essentials, including reusable menstrual cups, sterilizers, shaving kits, and more--each product developed with a focus on safety, comfort, and eco-friendliness.
Changing the Narrative Around Menstrual Health:
Despite growing awareness, menstruation in India still carries stigma. Matri addresses this by not only offering solutions but by contributing to a larger cultural change. Through its social media presence, collaborations, and campaigns around World Menstrual Hygiene Day, Matri promotes open conversations around period pain and reproductive health.
Scaling a Women-Centric Wellness Ecosystem:
As part of its future plans, Matri is expanding its reach across India, especially into Tier 2 and Tier 3 cities where access to menstrual health products remains limited.
The brand is also diversifying its offerings by launching new products line in women's hygiene and wellness, with the goal of becoming a holistic menstrual health company.
Matri's growth is fueled by community trust, research-driven design, and a mission to normalize conversations about periods. With each product iteration, the team incorporates user feedback to ensure comfort, effectiveness, and accessibility remain at the core.
About Matri:
Matri is an India-based women's wellness brand founded in 2020 by Roni Mondal and Rohan Roy. It is committed to providing safe, science-backed, and stigma-free solutions for menstrual health. Its flagship product, Matri Pro, is India's slimmest TENS-based pain relief device and has quickly become a trusted choice for thousands of women across the country. Matri aims to lead the period care revolution with compassion, technology, and purpose.
Learn More:
Visit the Official Store: https://mymatri.com
Follow Matri on Instagram: https://instagram.com/matriofficial
Like on Facebook: https://facebook.com/matriofficial
Visit: https://mymatri.com/products/matri-pro-menstrual-pain-relief-device
Media Contact:
Email: hello@mymatri.com
Website: https://mymatri.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
a day ago
- Business Standard
AMR crisis: Centre asks states to monitor antibiotic use in animals
In an effort to tackle the growing problem of antimicrobial resistance (AMR), which is estimated to claim 2 million lives in India by 2050, the Central Drugs Standard Control Organisation (CDSCO) has asked all state drug controllers to support the development of an antimicrobial use (AMU) reporting framework. The aim is to strengthen monitoring of antibiotic use in animals. For the first time, a joint working group will be formed, comprising representatives from the CDSCO, state licensing authorities (SLAs), and the Department of Animal Husbandry and Dairying (DAHD), to facilitate the implementation of the framework. Officials in the know said the framework will focus on the systematic collection of data on the sale, manufacture, and import of antibiotics for veterinary use. This move follows the Centre's release of the Standard Veterinary Treatment Guidelines for Livestock and Poultry (SVTG) in October last year. The guidelines emphasise minimising antibiotic use to prevent AMR in animals, mirroring similar efforts in human health. They provide symptomatic treatment guidance until a disease is laboratory-confirmed, ensuring minimal or no antibiotic use unless necessary. AMR occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines used to treat humans and animals. According to the World Health Organisation (WHO), around 10 million deaths are projected globally by 2050, with India expected to account for 2 million. In 2019, AMR was directly responsible for 1.27 million deaths globally, while 4.95 million were associated with drug-resistant infections. The WHO notes that the emergence and spread of AMR is accelerated by human activity — mainly the misuse and overuse of antimicrobials to treat, prevent, or control infections in humans, animals, and plants. Vegetables, poultry, and dairy products may contain antibiotic residues, which can enter the human bloodstream when consumed, further aggravating exposure. A recent study published in The Lancet Planetary Health stated that there are bidirectional associations between antibiotic consumption and AMR rates in humans and animals — that is, antibiotic use in animals can lead to AMR in humans, and vice versa. A separate study from 2015 estimated that nearly two-thirds of global antibiotic sales were for animal agriculture, with consumption projected to rise by another 67 per cent by 2030 due to increased demand for livestock products in low- and middle-income countries (LMICs). Coordinated action needed on new framework, says DCGI In a letter to all state and Union Territory (UT) drug controllers, Drug Controller General of India (DCGI) Rajeev Raghuvanshi called for coordinated action on AMU, specifically in the veterinary sector. The letter instructed all SLAs to nominate a nodal officer, not below the rank of assistant or joint drugs controller, to act as the point of contact for AMU data collection and coordination with the joint working group. It also asked state regulators to provide a comprehensive list of pharmaceutical companies involved in the manufacturing, distribution, and sale of veterinary antibiotics within their respective jurisdictions. In a separate letter dated 5 June, the DCGI also asked all zonal and sub-zonal offices of the CDSCO to share a list of approved drugs — including antibiotics, fixed drug combinations (FDCs), and their premixes — for veterinary use. A framework for AMU reporting is being seen as another key step to address AMR. Just last month, the central drug regulator released a draft guidance document for the safe disposal of unused or expired drugs, aimed at preventing AMR and other public health risks. The Centre had also urged pharmacists last year to dispense antibiotics only on the prescription of a qualified doctor, thereby limiting over-the-counter (OTC) sales. Under the Drugs and Cosmetics Rules, antibiotics are included in Schedule H — a list of drugs that may be sold by retail only on the prescription of a Registered Medical Practitioner (RMP).
Business Standard
4 days ago
- Business Standard
G.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and Nutraceuticals
India PR Distribution Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India's pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality. What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL's impressive timeline of achievements includes: - 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities - 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals - 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market -2018: Entry into the sports nutrition space - 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics - 2023: Establishment of a dedicated vaccine division to expand immunization solutions Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R & D, and a global network of manufacturing and distribution partners. "At GCCPL, innovation is not a buzzword--it's the foundation of our growth strategy," said Founder and Chairman Gautam Shah. "We're proud to be one of India's few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer." Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probiotic--both showcasing GCCPL's commitment to introducing clinically backed, innovative health solutions to India. With a sterling reputation for regulatory compliance, deep market research, and financial integrity--as affirmed by CRISIL's highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products. About G.C Chemie Pharmie Pvt. Ltd. Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today's market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.
Hans India
6 days ago
- Hans India
World Environment Day: Gadgets that help you build a healthier home
This World Environment Day, we're reminded that the environment we live in begins at home. With rising pollution levels and indoor air often more polluted than what's outside, ensuring clean air in our homes has never been more important. At Dyson, we believe that protecting the environment also means protecting the air we breathe. Our advanced air purification technology is designed to reduce indoor pollutants and allergens, helping create healthier living spaces for all. Explore Dyson's range of gadgets designed to improve indoor air quality, making it easier to breathe and helping to transform your home into a haven of clean air for World Environment Day and every day. Dyson V12s Detect Slim Submarine™ Dyson V12s Detect Slim Submarine™ wet and dry vacuum cleaner is designed to tackle various cleaning challenges, from dust and spills to stubborn stains. With a wet roller head and an eight-point hydration system, it effectively cleans up wet messes, while a motor-driven microfiber roller takes care of tough stains and debris. The vacuum cleaner features Dyson's 2x illuminating dust technology, ensuring that even the tiniest particles don't escape its cleaning prowess. Moreover, the included Hair screw tool makes it ideal for households with long hair or pets, as it efficiently collects hair without tangling around the brush. This World Environment Day, the Dyson V12s Detect Slim Submarine is available at Dyson stores as well as on for INR 55,900. Dyson WashG1™ cord-free wet floor cleaner The Dyson WashG1™ wet floor is designed for hygienic and effortless cleaning. It tackles wet and dry debris in one go, leaving floors with a barefoot-clean feel. With a 1-litre clean water tank and advanced hydration, absorption, and extraction technologies, it ensures every corner of their new space is spotless. Covering up to 3,100 sq. ft. on a single charge, it's perfect for maintaining a fresh and inviting home, making it an ideal addition to their happily-ever-after. Priced at INR 64,900, the Dyson WashG1™ cord-free wet floor is available at and Dyson stores. Dyson Purifier Big+Quiet
